14-day Premium Trial Subscription Try For FreeTry Free

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 152 days ( -207.85 % )
Last Price $20.01 0 %
High/ Low $20.01 - $20.01 0%
Chg 7 Days N/A $20.01 $20.01
Chg 30 Days N/A $20.01 $20.01
Chg 12 mos 82.91 % $10.94 $20.01
Trend - 3 mos N/A Width: 0.00000000 %
Trend - 12 mos 140.92 % Width: 82.78 %
Pred. range - 3 mos $20.01 - $20.01 0 % - 0 %
Pred. range - 12 mos $35.99 - $65.78 79.85 % - 228.74 %
Short MA avg 3 mos Sell Nov 30, -1 - N/A days
Long MA avg 3 mos Sell Nov 30, -1 - N/A days
Short/Long MA avg 3 mos Sell Nov 30, -1 - N/A days
Short MA avg 12 mos Buy Sep 27, 2022 - 85 days
Long MA avg 12 mos Buy Jul 06, 2022 - 143 days
Short/Long MA avg 12 mos Buy Jul 14, 2022 - 137 days
Pivot Short Sell Jan 26, 2023 - 2 days
Bollinger Sell Nov 30, -1 - N/A days
MACD N/A No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About Forma Therapeutics Holdings Inc.

Forma Therapeutics Holdings. Forma Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on development and commercialization of novel therapeutics for treatment of rare hematologic diseases and cancers. Its core product candidates for development include FT-4202, which is Phase 1 trial for the treatment of sickle cell disease and other hemoglobinopathies; and FT-7051 for the treatment of metastatic castration-resistant prostate cancer. The company... FMTX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT